Related Experiment Video
Updated: Jul 19, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
Truncating variants in p53AIP1 disrupting DNA damage-induced apoptosis are associated with prostate cancer risk
Xianshu Wang1, Fengwei Wang, Ken Taniguchi
1Department of Laboratory Medicine, Mayo Clinic/Mayo Clinical Medical College, Rochester, Minnesota 55905, USA.
Abstract:
Germ line mutations in several genes (BRCA1, BRCA2, and CHEK2) whose products are involved in the DNA damage-signaling pathway have been implicated in prostate cancer risk. To identify additional genes in this pathway that might confer susceptibility to this cancer, we analyzed a recently identified DNA damage-response gene, p53AIP1 (a gene encoding for p53-regulated apoptosis-inducing protein 1), for genetic variants in prostate cancer. Five novel germ line variants were identified. The two truncating variants (Ser(32)Stop and Arg(21)insG) were found in 3% (4 of 132) of unselected prostate tumor samples. Genotyping of the two variants in an additional 393 men with sporadic prostate cancer showed a frequency of 3.1% (12 of 393) in contrast to 0.6% (2 of 327) in 327 unaffected men (Fisher's exact test, P = 0.018), with an odds ratio (OR) of 5.1 [95% confidence interval (95% CI), 1.1-23.0]. In addition, two of six tumors carrying the truncating variants were associated with loss of heterozygosity of the wild-type alleles, suggesting that p53AIP1 may act as a tumor suppressor. We also showed that the truncated p53AIP1 was unable to induce apoptosis and suppress cell growth in HeLa and COS-7 cells. These results suggest that loss-of-function variants in p53AIP1 associated with the risk of sporadic prostate cancer and further support the concept that the genetic defects in the DNA damage-response genes play an important role in the development of prostate cancer.
Insights
Germ line variants in the p53AIP1 gene, involved in DNA damage response, increase prostate cancer risk. Loss-of-function mutations in p53AIP1 may contribute to sporadic prostate cancer development.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Prostate cancer risk is linked to germ line mutations in DNA damage-signaling genes like BRCA1, BRCA2, and CHEK2.
- Identifying additional susceptibility genes within this pathway is crucial for understanding prostate cancer etiology.
Purpose of the Study:
- To investigate the role of the DNA damage-response gene p53AIP1 (p53-regulated apoptosis-inducing protein 1) in prostate cancer susceptibility.
- To identify and characterize novel germ line variants of p53AIP1 in prostate cancer patients.
Main Methods:
- Analysis of germ line DNA for p53AIP1 variants in prostate cancer patients and controls.
- Genotyping of identified variants in larger cohorts.
- Functional assays in cell lines to assess the impact of truncated p53AIP1 on apoptosis and cell growth.
Main Results:
- Five novel germ line variants in p53AIP1 were identified, including two truncating variants (Ser(32)Stop and Arg(21)insG).
- Truncating p53AIP1 variants were found at a significantly higher frequency in sporadic prostate cancer patients (3.1%) compared to controls (0.6%), yielding an odds ratio of 5.1.
- Loss of heterozygosity for wild-type p53AIP1 alleles was observed in tumors with truncating variants, and truncated p53AIP1 failed to induce apoptosis or suppress cell growth in functional assays.
Conclusions:
- Loss-of-function variants in p53AIP1 are associated with an increased risk of sporadic prostate cancer.
- These findings highlight the importance of DNA damage-response gene defects in prostate cancer development and suggest p53AIP1 may function as a tumor suppressor.
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
The Intrinsic Apoptotic Pathway
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

